| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/15/2023 | Esperion Therapeutics, Inc. | ESPR | Grant | Common Stock | 5.2k | $0.00 | $0 | | 06/15/2023 |
| 06/15/2023 | Esperion Therapeutics, Inc. | ESPR | Grant | Stock Option (right to buy) | 21k | $1.37 | $28.8k | | 06/15/2023 |
| 05/24/2023 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Common Stock | 4.6k | $0.00 | $0 | | 05/24/2023 |
| 05/24/2023 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 13.8k | $32.27 | $444.5k | | 05/24/2023 |
| 01/01/2023 | Tyra Biosciences, Inc. | | Grant | Stock Option (Right to Buy) | 328k | $7.60 | $2.5M | | 01/01/2023 |
| 01/01/2023 | Tyra Biosciences, Inc. | | Grant | Stock Option (Right to Buy) | 32.8k | $7.60 | $249.3k | | 01/01/2023 |
| 05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 246.7k | $3.93 | $969.4k | | 05/31/2022 |
| 05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 10k | $6.27 | $62.9k | | 05/31/2022 |
| 05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 22.7k | $2.62 | $59.6k | | 05/31/2022 |
| 05/19/2022 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 15.3k | $35.42 | $542.6k | | 05/19/2022 |
| 05/19/2022 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Common Stock | 4.8k | $0.00 | $0 | | 05/19/2022 |
| 10/27/2021 | Checkmate Pharmaceuticals, Inc. | CMPI | Grant | Stock Option (Right to Buy) | 246.7k | $3.93 | $969.4k | | 10/27/2021 |
| 06/16/2021 | Checkmate Pharmaceuticals, Inc. | CMPI | Grant | Stock Option (Right to Buy) | 10k | $6.27 | $62.9k | | 06/16/2021 |
| 05/27/2021 | Esperion Therapeutics, Inc. | ESPR | Grant | Common Stock | 12.4k | $0.00 | $0 | | 05/27/2021 |
| 05/20/2021 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Common Stock | 1.1k | $0.00 | $0 | | 05/20/2021 |
| 05/20/2021 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 7k | $75.94 | $531.4k | | 05/20/2021 |
| 05/28/2020 | Esperion Therapeutics, Inc. | ESPR | Grant | Common Stock | 1.2k | $0.00 | $0 | | 05/28/2020 |
| 05/20/2020 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 7.5k | $38.03 | $283.9k | | 05/20/2020 |
| 05/15/2020 | Esperion Therapeutics, Inc. | ESPR | Grant | Common Stock | 11k | $0.00 | $0 | | 05/15/2020 |
| 09/12/2019 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 30k | $18.00 | $539.7k | | 09/12/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 13k | $11.35 | $147.6k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 7.8k | $20.91 | $163.3k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 7.8k | $24.18 | $188.9k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 11k | $78.58 | $864.4k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 8.8k | $180.98 | $1.6M | | 02/15/2019 |
| 06/13/2018 | Loxo Oncology, Inc. | LOXO | Grant | Director Stock Option (right to buy) | 8.8k | $180.98 | $1.6M | | 06/13/2018 |
| 06/08/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 2.6k | $178.07 | $467.4k | | 06/08/2018 |
| 06/08/2018 | Loxo Oncology, Inc. | LOXO | Exercise | Director Stock Option (right to buy) | 2.6k | $11.35 | $29.8k | | 06/08/2018 |
| 06/22/2017 | Loxo Oncology, Inc. | LOXO | Grant | Director Stock Option (right to buy) | 11k | $78.58 | $864.4k | | 06/22/2017 |
| 06/10/2016 | Loxo Oncology, Inc. | LOXO | Grant | Director Stock Option (right to buy) | 7.8k | $24.18 | $188.9k | | 06/10/2016 |
| 03/11/2016 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (Right to Buy) | 60k | $4.36 | $261.6k | | 03/11/2016 |
| 09/30/2015 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (Right to Buy) | 167.2k | $7.00 | $1.2M | | 09/30/2015 |
| 07/28/2015 | Loxo Oncology, Inc. | LOXO | Grant | Director Stock Option (right to buy) | 7.8k | $20.91 | $163.3k | | 07/28/2015 |
| 01/12/2015 | Loxo Oncology, Inc. | LOXO | Grant | Director Stock Option (right to buy) | 15.6k | $11.35 | $177.3k | | 01/12/2015 |